The Federal Trade Commission is launching a probe into recent shortages of chemotherapies and other drugs, examining the role played by companies that help buy and distribute the bulk of medicines sold to U.S. hospitals.
The inquiry shines a spotlight on a little-noticed corner of the drug supply chain—but one that can have an outsize impact on stores of critical medicines.
What is the difference between a foldable phone and a flip phone?
The smartphone world has moved beyond the “black glass slab” era. We are now firmly in the age of flexible
